A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences